The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Factor Replacement Therapy, Non-Factor Replacement Therapies, Gene Therapy), By Route of Administration (Intravenous, Oral, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hemophilia A Treatment Market is projected for significant growth, expanding from USD 14.73 Billion in 2025 to USD 21.44 Billion by 2031, representing a Compound Annual Growth Rate (CAGR) o...
May 2026
185 pages
Hyperuricemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary, Secondary), By Drug Type (Xanthine Oxidase Inhibitors, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global hyperuricemia market, which includes urate-lowering therapeutics and diagnostic tools for managing elevated serum uric acid, is projected to expand from USD 4.78 billion in 2025 to USD 7.13...
May 2026
185 pages
Iron Deficiency Anemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Others), By Therapy Areas (Obstetrics and Gynecology, Oncology, Congestive Heart Failure (CHF), Inflammatory Bowel Disease, Renal, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Iron Deficiency Anemia Market, comprising therapeutic solutions like oral and parenteral iron formulations aimed at replenishing iron stores and normalizing hemoglobin levels, is projected...
May 2026
180 pages
Opioid Use Disorder Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Agonist Drugs, Antagonist Drugs, Others), By Route of Administration (Oral, Parenteral, Sublingual, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Opioid Use Disorder (OUD) Drugs Market is projected to expand robustly from USD 3.89 Billion in 2025 to USD 6.81 Billion by 2031, at a Compound Annual Growth Rate of 9.78%. This market enco...
May 2026
180 pages
Rheumatology Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Ankylosing Spondylitis, Gout, Osteoarthritis, Psoriatic Arthritis, Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Rheumatology Therapeutics Market is projected to expand from USD 49.68 Billion in 2025 to USD 58.19 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 2.67%. This market...
May 2026
182 pages
Rosai-Dorfman Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Classic (nodal) Rosai-Dorfman disease, Extranodal Rosai-Dorfman disease), By Procedure Type (Diagnosis, Treatment), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Rosai-Dorfman Disease (RDD) market is projected to expand from USD 533.12 billion in 2025 to USD 772.22 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.37%. RDD is a r...
May 2026
182 pages
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Drug Treatment {Anti-inflammatories (NSAIDS), Tumor Necrosis Factor (TNF) Blockers, Muscle Relaxants, Immune Suppressants Drugs, Disease Modifying Antirheumatic Drugs, Others}, Biologics, Other), By Route of Administration (Oral, Injectables, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Systemic Juvenile Idiopathic Arthritis Market is projected to expand from USD 1.93 Billion in 2025 to USD 2.31 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 3.04%. Sys...
May 2026
185 pages
Xerostomia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Xerostomia Therapeutics Market is projected to expand from USD 2.74 Billion in 2025 to USD 3.47 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 4.02%. These therapeutics...
May 2026
192 pages
Acquired Orphan Blood Diseases Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Recombinant Factor, Immunoglobulin Infusion Therapy, Activated Prothrombin Complex Concentrate, Thrombopoietin Receptor Agonists, Others), By Disease Indication (Acquired Agranulocytosis, Acquired Hemophilia, Acquired Von Willebrand Syndrome, Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for therapeutics targeting acquired orphan blood diseases is projected to expand significantly, from USD 8.13 billion in 2025 to USD 12.82 billion by 2031, demonstrating a compound a...
May 2026
182 pages
Bulk Drug Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Antibiotics, Sulpha Drugs, Vitamins, Steroids, Analgesics, Others), By End-User (Pharmaceuticals, Biotechnology, Veterinary Medicine), By Region & Competition, 2021-2031F
US$ 4,500.00
The global bulk drug market, encompassing Active Pharmaceutical Ingredients (APIs), is projected for substantial growth, expanding from USD 465.12 billion in 2025 to USD 925.96 billion by 2031 with a...
May 2026
182 pages
Chronic Pain Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Neuropathic Pain, Analgesic Infusion, Ablation), By Product Type (Drugs, Devices), By Distribution Channel (Hospital & Clinics, Ambulatory Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Chronic Pain Treatment Market is projected to expand significantly, rising from USD 86.23 Billion in 2025 to USD 136.53 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) o...
May 2026
180 pages
Fabry Disease Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (Agalsidase Beta, Migalastat, Others), By Treatment (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), others), By Route of Administration (Oral, Parenteral, others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Fabry Disease Treatment Market is projected to expand from USD 1.94 Billion in 2025 to USD 2.81 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.37%. This market foc...
May 2026
185 pages
Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH), By Application (Venous Thromboembolism, Coronary Artery Disease, Renal Impairment, Atrial Fibrillation, Others), By Route of Administration (Intravenous, Subcutaneous), By End Use (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Heparin Market is projected to expand from USD 6.56 Billion in 2025 to USD 9.34 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.07%. Heparin, an injectable anticoag...
May 2026
185 pages
Lysosomal Storage Diseases Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, others), By Indication (Gaucher's Disease, Fabry Disease, Pompe's Disease, Mucopolysaccharidosis, others), By End User (Hospitals, Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lysosomal Storage Diseases Therapeutics Market is projected to expand from USD 7.69 Billion in 2025 to USD 11.72 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.28%...
May 2026
182 pages
Metabolic Disorders Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Disease Type (Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Others), By Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Metabolic Disorders Therapeutics Market is projected for substantial growth, expanding from USD 74.81 Billion in 2025 to USD 116.88 Billion by 2031, at a Compound Annual Growth Rate of 7.72...
May 2026
185 pages
Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Calcitonin, Insulin, Linaclotide, Octreotide, Plecanatide), By Application (Bone Diseases, Diabetes, Gastric & Digestive Disorders, Hormonal Disorders), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for oral proteins and peptides is projected to expand significantly, from USD 1.37 billion in 2025 to USD 2.36 billion by 2031, exhibiting a compound annual growth rate of 9.49%. The...
May 2026
185 pages
Pleurodynia Treatment Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Diagnosis (Blood test, Culture test, X-ray), By Treatment (Analgesics or Painkillers, Immunoglobulin), By Mode of Administration (Oral, Injections or infusion), By End-User (Hospitals, Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pleurodynia Treatment Market is projected to expand from USD 152.11 Million in 2025 to USD 207.48 Million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.31%. This market enco...
May 2026
180 pages
Pompe Disease Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Treatment Type (Drugs, Enzyme Replacement Therapy, Physical Therapy, Chaperone-Advanced Replacement Therapy), By Route of Administration (Oral, Parenteral), By End User (Hospitals & Speciality Clinics, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pompe Disease Therapeutics Market is projected to expand from USD 1.55 Billion in 2025 to USD 2.02 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 4.51%. This market pri...
May 2026
182 pages
Synthetic Hormones Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), By Route of Administration (Intravenous, Nasal, Oral, Suppository, Topical), By Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency), By End User (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Region, and Competition, 2021-2031F
US$ 4,500.00
The Global Synthetic Hormones Market is projected to expand significantly, growing from USD 619.12 Million in 2025 to USD 1242.47 Million by 2031, demonstrating a robust 12.31% Compound Annual Growth...
May 2026
177 pages
Global Microecological Drugs Market Growth 2026-2032
US$ 3,660.00
The global Microecological Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Microecological drugs refer t...
May 2026
147 pages
Genitourinary Drugs Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence & Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), By Product (Hormonal Therapy, Gynecological, Urologicals, Anti-infectives, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global genitourinary drugs market is anticipated to expand from USD 28.79 billion in 2025 to USD 33.56 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 2.59%. This sector enc...
May 2026
180 pages
Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Acute Graft Versus Host Disease, Chronic Graft Versus Host Disease), By Product (Corticosteroids, Monoclonal Antibodies, Tyrosine Kinase Inhibitors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Graft Versus Host Disease Treatment Market is projected to expand from USD 2.99 Billion in 2025 to USD 4.58 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.37%. This m...
May 2026
185 pages
Blind Loop Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Tetracycline, Chlortetracycline, Oxytetracycline, Chloramphenicol), By Route of Administration (Injectable, Oral, Parenteral), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Blind Loop Syndrome Market is projected to expand from USD 13.22 Billion in 2025 to USD 18.17 Billion by 2031, registering a CAGR of 5.44%. Blind Loop Syndrome, frequently managed under the...
May 2026
180 pages
Castleman Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Multicentric Castlemans Disease, Unicentric Castlemans Disease), By Indication (Angiofollicular Lymph Node Hyperplasia, Angiomatous Lymphoid, Castleman Tumor, Giant Benign Lymphoma, Giant Lymph Node Hyperplasia, Hamartoma of the Lyphatics), By Therapy (Antiviral Drugs, Chemotherapy, Corticosteroids, Immunotherapy, Monoclonal Antibodies, Radiation Therapy), By End-user (Hospitals, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Castleman Disease Treatment Market is projected to expand from USD 0.28 Billion in 2025 to USD 0.52 Billion by 2031, registering a compound annual growth rate of 10.87%. This market sector...
May 2026
189 pages
Hereditary Angioedema Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application (Prophylaxis, On-demand), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Hereditary Angioedema (HAE) therapeutics market is projected to expand significantly, increasing from USD 4.41 billion in 2025 to USD 7.36 billion by 2031, demonstrating an 8.91% compound a...
May 2026
177 pages
IgA Nephropathy Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Test (Blood Test, Urine Test, Kidney Biopsy, Iothalamate Clearance Test, Others), By Treatment Type (Corticosteroids, Immunosuppressive Drugs, ACE Inhibitors And ARBs, Diet Change, Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global IgA Nephropathy Disease Treatment Market is projected to expand from USD 173.75 Million in 2025 to USD 241.08 Million by 2031, achieving a compound annual growth rate of 5.61%. Treatment re...
May 2026
180 pages
Alport Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Tablets, Capsules, Injectable, Others), By Disease Type (X-linked Alport Syndrome, Autosomal Recessive Alport Syndrome, Autosomal Dominant Alport Syndrome), By End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Alport Syndrome Treatment Market is projected to grow from USD 12.19 Million in 2025 to USD 16.82 Million by 2031, demonstrating a 5.51% CAGR. This market focuses on pharmacological therapi...
May 2026
180 pages
Anti Osteoporosis Therapy and Fracture Healing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Calcitonin, Bisphosphonates, Hormone Replacement Therapy, Anabolic, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for anti-osteoporosis therapy and fracture healing is projected to expand significantly, rising from USD 15.34 billion in 2025 to USD 19.97 billion by 2031, at a compound annual grow...
May 2026
188 pages
Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Factor Concentrates, Fresh Frozen Plasma, Cryoprecipitate, Others), By Type (Factor I, Factor II, Factor V, Factor VII, Factor X, Factor XI, Factor XIII) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Rare Hemophilia Factors Market is projected to expand significantly, growing from USD 345.11 million in 2025 to USD 506.69 million by 2031, at a compound annual growth rate (CAGR) of 6.61%....
May 2026
180 pages
Cannabidiol Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End User (Medical {Chronic Pain, Mental Disorder, Cancer, Others}, Personal Use, Pharmaceuticals, Wellness {Food & Beverage, Personal Care & Cosmetics, Nutraceuticals, Others}), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cannabidiol Market is projected to expand from USD 6.88 Billion in 2025 to USD 14.07 Billion by 2031, reflecting a compound annual growth rate of 12.66%. Derived primarily from the Cannabis...
May 2026
185 pages
Liver Fibrosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Interferon Therapy, Maloti Lipid, Nucleoside Analog), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for liver fibrosis drugs is projected to expand significantly, rising from USD 19.12 billion in 2025 to USD 33.91 billion by 2031, demonstrating a robust Compound Annual Growth Rate...
May 2026
180 pages
Peptides and Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Peptides, Heparin), By Application (Oncology, Metabolic Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Anticoagulation Therapy, Others), By Route of Administration (Injectable, Oral, Others), By End User (Hospitals and Clinics, Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for peptides and heparin is projected to expand significantly, rising from USD 13.41 billion in 2025 to USD 21.72 billion by 2031, reflecting an 8.37% compound annual growth rate. Pe...
May 2026
180 pages
Povidone Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use Application (Pharmaceutical, Food & Beverages, Personal Care & Cosmetics, Adhesives, and Others), By Sales Channel (Direct Sale, Indirect Sale), By Region & Competition, 2021-2031F
US$ 4,500.00
The global povidone market is projected to expand from USD 1.12 billion in 2025 to USD 1.55 billion by 2031, achieving a compound annual growth rate (CAGR) of 5.56%. Povidone, scientifically termed Po...
May 2026
180 pages
Sodium Ascorbate Excipient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use Application (Pharmaceuticals, Food & Beverages, and Others), By Sales Channel (Direct Sale, Indirect Sale), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Sodium Ascorbate Excipient Market is projected to expand significantly, from USD 263.32 Million in 2025 to USD 443.32 Million by 2031, at a 9.07% compound annual growth rate. This critical...
May 2026
180 pages
Clavulanic Acid Series API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Potassium Clavulanate, Amoxicillin & Potassium Clavulanate, Potassium Clavulanate with Avicel, Potassium Clavulanate with Silicon Dioxide), By Application (Oral Medications and Injectable Medications), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clavulanic Acid Series API Market is projected to expand significantly, rising from USD 394.22 Million in 2025 to USD 587.32 Million by 2031, demonstrating a Compound Annual Growth Rate (CA...
May 2026
185 pages
Acute Pancreatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments), By Diagnosis (Imaging tests, Laboratory Tests), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Acute Pancreatitis Market is projected to expand from USD 5.21 Billion in 2025 to USD 7.23 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.61%. Acute pancreatitis, an...
May 2026
182 pages
Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (NS3/4A Protease, NS5A Protein, NS5B RNA-Dependent RNA polymerase), By Indication (Hepatitis C Virus, HIV Infection/ AIDS, Influenza, Prophylaxis), By Route (Intravenous, Oral, Subcutaneous, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Direct-acting Antiviral Drug Market is projected to expand significantly, growing from USD 11.91 Billion in 2025 to USD 23.71 Billion by 2031, demonstrating a robust CAGR of 12.16%. Direct-...
May 2026
180 pages
Lactose Intolerance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Primary, Secondary, Congenital, Developmental), By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test), By Region & Competition, 2021-2031F
US$ 4,500.00
The global lactose intolerance market is projected to expand significantly, from USD 21.67 billion in 2025 to USD 32.14 billion by 2031, growing at a 6.79% CAGR. This market includes specifically form...
May 2026
188 pages
Marine Derived Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Ether, Peptide, Phenol, Steroid), By Source (Algae, Invertebrates, Microorganisms), By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Marine Derived Drugs Market is projected to expand significantly, from USD 13.02 billion in 2025 to USD 21.99 billion by 2031, demonstrating a compound annual growth rate of 9.13%. This mar...
May 2026
177 pages
Psychedelic Drug Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Type (Lysergic Acid Diethylamide, Gamma Hydroxybutyric Acid, Ketamine, Psilocybin, Others), By Application (Treatment-Resistant Depression, Opiate Addiction, Post-Traumatic Stress Disorder, Narcolepsy, Panic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Psychedelic Drug Market is projected to expand significantly, rising from USD 4.62 Billion in 2025 to USD 8.46 Billion by 2031, demonstrating a 10.61% compound annual growth rate. This mark...
May 2026
185 pages
Amphotericin B Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Systemic Fungal Infections, Candidiasis, Aspergillosis, Mucormycosis, Leishmaniasis, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Amphotericin B Market is forecast to grow from USD 561.05 Million in 2025 to USD 733.15 Million by 2031, exhibiting a 4.56% CAGR. Amphotericin B, a broad-spectrum polyene antifungal antibio...
May 2026
180 pages
Cefaclor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Lung Infection, Skin Infection, Ear Infection, Throat Infection, Tonsils, Urinary Tract Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Cefaclor market is projected to expand from USD 352.67 million in 2025 to USD 440.35 million by 2031, exhibiting a compound annual growth rate (CAGR) of 3.77%. Cefaclor, a second-generation...
May 2026
180 pages
Cefpodoxime Proxetil Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Ear Infection, Nose Infection, Throat Infection, Lower Respiratory Tract Infection, Urinary Tract Infection, Skin Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cefpodoxime Proxetil Market is projected to expand from USD 2.96 Billion in 2025 to USD 4.12 Billion by 2031, demonstrating a compound annual growth rate of 5.67%. Cefpodoxime Proxetil, an...
May 2026
180 pages
Cefuroxime Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By Grade (Axetil, Sodium), By End Use (Bronchitis, Gonorrhea, Lyme Disease, Skin Infection, Ear Infection, Throat Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cefuroxime Market is projected to expand from USD 546.34 Million in 2025 to USD 746.49 Million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.34%. This market revolves around...
May 2026
189 pages
Cephalexin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Urinary Tract Infection, Respiratory Infection, Otitis Media, Bone Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cephalexin Market is projected to expand from USD 389.03 Million in 2025 to USD 511.58 Million by 2031, reflecting a compound annual growth rate of 4.67%. Cephalexin, a first-generation cep...
May 2026
177 pages
Clarithromycin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pneumonia, Bronchitis, Ear Infection, Skin Infection, Throat Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clarithromycin Market is projected to expand from USD 345.17 Million in 2025 to USD 423.07 Million by 2031, demonstrating a Compound Annual Growth Rate of 3.45%. This growth is underpinned...
May 2026
182 pages
Etoricoxib Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Acute Gouty Arthritis, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Etoricoxib market is projected to grow substantially from USD 123.21 Million in 2025 to USD 245.94 Million by 2031, demonstrating a 12.21% CAGR. Etoricoxib, a selective COX-2 inhibitor non-...
May 2026
182 pages
Fusidic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global fusidic acid market is projected to expand from USD 31.12 million in 2025 to USD 35.27 million by 2031, at a CAGR of 2.11%. This bacteriostatic antibiotic, derived from Fusidium coccineum,...
May 2026
185 pages
